X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2476) 2476
Publication (315) 315
Book Review (84) 84
Book / eBook (41) 41
Book Chapter (32) 32
Newsletter (8) 8
Newspaper Article (7) 7
Dissertation (3) 3
Conference Proceeding (2) 2
Magazine Article (2) 2
Web Resource (2) 2
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2122) 2122
index medicus (1542) 1542
female (1177) 1177
oncology (959) 959
cancer (920) 920
animals (776) 776
middle aged (614) 614
inflammation (555) 555
breast cancer (517) 517
male (511) 511
adult (447) 447
aged (447) 447
research (444) 444
cell line, tumor (371) 371
chemotherapy (366) 366
tumors (357) 357
apoptosis (348) 348
mice (344) 344
breast neoplasms - drug therapy (343) 343
care and treatment (341) 341
health aspects (327) 327
metastasis (313) 313
anti-inflammatory agents, non-steroidal - therapeutic use (306) 306
breast-cancer (305) 305
risk factors (298) 298
neoplasms - drug therapy (278) 278
medicine (270) 270
research article (262) 262
breast neoplasms - pathology (253) 253
expression (251) 251
colorectal cancer (243) 243
cancer therapies (239) 239
pharmacology & pharmacy (234) 234
review (233) 233
anti-inflammatory agents, non-steroidal - pharmacology (232) 232
proteins (227) 227
inflammatory bowel disease (226) 226
article (224) 224
gene expression (224) 224
prognosis (224) 224
colorectal-cancer (222) 222
nonsteroidal anti-inflammatory drugs (222) 222
cytokines (217) 217
anti-inflammatory agents - therapeutic use (212) 212
antineoplastic agents - pharmacology (210) 210
analysis (203) 203
cell proliferation - drug effects (203) 203
studies (203) 203
treatment outcome (198) 198
nonsteroidal antiinflammatory drugs (196) 196
antineoplastic agents - therapeutic use (195) 195
nf-kappa-b (195) 195
apoptosis - drug effects (191) 191
signal transduction (191) 191
biochemistry & molecular biology (190) 190
development and progression (190) 190
immunology (189) 189
anti-inflammatory agents - pharmacology (187) 187
cell biology (185) 185
survival (177) 177
drug therapy (174) 174
genetic aspects (173) 173
science (172) 172
inflammatory-bowel-disease (171) 171
multidisciplinary sciences (171) 171
angiogenesis (170) 170
prevention (168) 168
patients (165) 165
therapy (165) 165
carcinoma (161) 161
risk (161) 161
surgery (160) 160
in-vitro (157) 157
aspirin (153) 153
biology (152) 152
antineoplastic combined chemotherapy protocols - therapeutic use (151) 151
cells (145) 145
kinases (143) 143
medical prognosis (143) 143
aged, 80 and over (134) 134
inflammatory diseases (134) 134
inflammatory breast cancer (133) 133
medical research (131) 131
activation (130) 130
neoplasms. tumors. oncology. including cancer and carcinogens (130) 130
diagnosis (129) 129
medicine, research & experimental (129) 129
physiological aspects (129) 129
neoplasms - metabolism (126) 126
retrospective studies (125) 125
gastroenterology & hepatology (124) 124
neoplasms - pathology (122) 122
signal transduction - drug effects (120) 120
epidemiology (118) 118
inflammation - drug therapy (118) 118
inhibition (118) 118
chemoprevention (116) 116
rodents (114) 114
disease models, animal (111) 111
oncology, experimental (111) 111
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (32) 32
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Online Resources - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2517) 2517
French (13) 13
Japanese (10) 10
German (7) 7
Spanish (4) 4
Dutch (3) 3
Italian (2) 2
Polish (2) 2
Portuguese (2) 2
Chinese (1) 1
Czech (1) 1
Danish (1) 1
Finnish (1) 1
Norwegian (1) 1
Russian (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 6, pp. 640 - 647
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2012, Volume 136, Issue 2, pp. 331 - 345
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2013, Volume 31, Issue 14, pp. 1719 - 1725
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 791 - 800
Journal Article
Cancer Research, ISSN 0008-5472, 12/2010, Volume 70, Issue 24, pp. 10288 - 10298
Journal Article
British Journal of Cancer, ISSN 0007-0920, 10/2013, Volume 109, Issue 7, pp. 1921 - 1925
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2278 - 2284
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 16, pp. 4780 - 4792
Purpose: Inflammatory breast cancer (IBC), diagnosed clinically, and triple-negative breast cancer (TNBC), diagnosed by molecular receptor status, are the two... 
CELL LUNG-CANCER | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | SELUMETINIB AZD6244 | INDUCED APOPTOSIS | IN-VIVO | DOWN-REGULATION | LEUKEMIA-CELLS | PHASE-II | EXPRESSION | XENOGRAFT MODEL | Niacinamide - analogs & derivatives | Apoptosis - drug effects | Humans | Histone Deacetylase Inhibitors - administration & dosage | Myeloid Cell Leukemia Sequence 1 Protein - metabolism | Apoptosis - genetics | Triple Negative Breast Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Breast Neoplasms - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Benzamides - administration & dosage | Inflammatory Breast Neoplasms - drug therapy | Inflammatory Breast Neoplasms - metabolism | Female | Benzamides - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Cell Proliferation - genetics | Pyridines - administration & dosage | Kaplan-Meier Estimate | Inflammatory Breast Neoplasms - genetics | Breast Neoplasms - drug therapy | Myeloid Cell Leukemia Sequence 1 Protein - genetics | Niacinamide - administration & dosage | Drug Synergism | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Animals | Breast Neoplasms - genetics | Triple Negative Breast Neoplasms - genetics | Mice, Nude | Triple Negative Breast Neoplasms - metabolism | Cell Line, Tumor | Histone Deacetylase Inhibitors - pharmacology | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Niacinamide - pharmacology | Proto-Oncogene Proteins c-bcl-2 - genetics | Therapy | Histone deacetylase | Target recognition | Bcl-2 protein | Extracellular signal-regulated kinase | Breast cancer | Inflammation | Gene expression | Synergism | Mcl-1 protein | Degradation | Mitochondria | Inhibitors | Experimental design | Cell death | Cell lines | Breast | In vivo methods and tests | Inhibition | Health risk assessment | Cancer | Apoptosis | Entinostat | Inflammatory breast cancer | Pimasertib | PMAIP1 | NOXA | Triple-negative breast cancer | MCL1
Journal Article
Annals of Oncology, ISSN 0923-7534, 02/2014, Volume 25, Issue 2, pp. 384 - 391
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2013, Volume 19, Issue 22, pp. 6163 - 6172
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 2009, Volume 47, Issue 1, pp. 13 - 26
Poly(ADP-ribose) polymerases (PARPs) are defined as cell signaling enzymes that catalyze the transfer of ADP-ribose units from NAD to a number of acceptor... 
BRCA1/2 | Angiogenesis | Stroke | Free radicals | Homologous recombination | Sepsis | Cardiovascular disease | PARP | Inflammation | poly(ADP-ribose) | Diabetes | Anticancer therapy | POLY(ADP-RIBOSE) POLYMERASE | NITRIC-OXIDE SYNTHASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOCAL CEREBRAL-ISCHEMIA | HEART-FAILURE | DIABETIC ENDOTHELIAL DYSFUNCTION | DNA-REPAIR DEFECT | ADP-RIBOSE POLYMERASE | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | NF-KAPPA-B | Cell Transformation, Neoplastic - radiation effects | Poly(ADP-ribose) Polymerases - immunology | Poly(ADP-ribose) Polymerases - therapeutic use | Humans | Reperfusion Injury - drug therapy | Radiotherapy - adverse effects | DNA Mismatch Repair - genetics | Breast Neoplasms - physiopathology | Radiation-Sensitizing Agents - therapeutic use | Cell Transformation, Neoplastic - genetics | Drug-Related Side Effects and Adverse Reactions | Angiogenesis Inhibitors - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Female | Oxidative Stress - radiation effects | Gene Expression Regulation, Neoplastic - drug effects | BRCA1 Protein - deficiency | Autoimmune Diseases - drug therapy | Gene Expression Regulation, Neoplastic - genetics | DNA Mismatch Repair - radiation effects | Oxidative Stress - genetics | DNA Mismatch Repair - drug effects | Clinical Trials as Topic | Combined Modality Therapy | Breast Neoplasms - blood supply | Breast Neoplasms - drug therapy | Poly(ADP-ribose) Polymerase Inhibitors | Breast Neoplasms - radiotherapy | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Neovascularization, Pathologic - drug therapy | BRCA2 Protein - deficiency | Gene Expression Regulation, Neoplastic - radiation effects | Cell Transformation, Neoplastic - drug effects | Oxidative Stress - drug effects | Poly (ADP-Ribose) Polymerase-1 | Rheumatoid factor | Enzymes | Chemotherapy | Cell death | Rheumatoid arthritis | DNA | Development and progression | DNA binding proteins | Health aspects | Cancer | Index Medicus
Journal Article